Drug major Dr Reddy's Laboratories today reported 25.74 per cent increase in its consolidated net profit at Rs 721.89 crore for the second quarter ended September 30.
The company had posted a net profit of Rs 574.10 crore during the same period of previous fiscal.
Net income from sales and services rose to Rs 3,988.96 crore during the quarter under review, as against Rs 3,587.81 crore in the same period of previous fiscal, Dr Reddy's said in a BSE filing.
"We had robust sales growth across our markets of US, India and Europe, supported by new products that were launched in the past twelve months," Dr Reddy's Laboratories co-chairman and CEO GV Prasad said.
Dr Reddy's Laboratories shares today ended 2.59 per cent up at Rs 4,214.05 apiece on the BSE.
